Filmsugen?

PHI`s kompis Nexus Scientific i USA har genomfört ett webinarium man igår la ut på tuben. 
Live Cell Imaging utan infärgning är stekhett. Intresset ser ut att öka bland forskarna,därav detta webinarium mest troligt.

QPI? En förkortning som VD-Patrik ofta återkommer till, b.l.a i senaste intervjun : 

– PHI’s non-invasive QPI technology is one of the few technologies that can be used for quality control within regenerative medicine, empowering PHI at the forefront of this breakthrough in medicine.

QPI står för Quantitative Phase Imaging. Nexus tar upp det i filmen och förklarar pedagogiskt.

Nexus Label-free Live Cell Imaging Webinar

"We feel that the HoloMonitor should be in every cell biology lab"

Bloggen kan inte annat än hålla med i den åsikten.

-----------------------------------------------------------------------------------

Och en sent inkommen nyhet inom den Regenerativa Medicinen : FDA kommer godkänna ett nytt läkemedel för Alzheimers.

Regenerative Medicine Foundation.

Breaking: First Alzheimer’s drug to slow disease progression is expected to get full FDA approval.

CNN has the latest news of this breakthrough: 

Thu July 6, 2023 

First Alzheimer’s drug to slow disease progression gets full FDA approval, triggering broader Medicare coverage

CNN — 

The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.

The Centers for Medicare and Medicaid Services said Thursday that it will now expand coverage of the drug, broadening access for up to an estimated million people with early forms of the disease.

“Today’s action is the first verification that a drug targeting the underlying disease process of Alzheimer’s disease has shown clinical benefit in this devastating disease,” Teresa Buracchio, acting director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research, said in the announcement. “This confirmatory study verified that it is a safe and effective treatment for patients with Alzheimer’s disease.”

‘The beginning of a new era’

The drug was approved only for people with early forms of Alzheimer’s disease, those with mild cognitive impairment or mild dementia who have been confirmed to have amyloid plaques in their brains. Dr. Lawrence Honig, a professor of neurology at Columbia University Irving Medical Center, estimates that group constitutes about a sixth of the more than 6 million Americans currently diagnosed with Alzheimer’s.

Min kommentar
Fråga : Ligger PHI och HoloMonitor rätt i tiden?
Svar : Sover Dolly Parton på rygg?

(dum fråga får dumt svar,häpp 😎)

                                     Mvh the99

Ps.Bull-generatorn fixade 2 bullar till kaffet igår,så nu blir det bullfrossa 😍